Keyword: HealthPrize Technologies
Boehringer Ingelheim recently expanded its RespiPoints online rewards program because it works, with adherence of over 50% after nine months. Now, four of its respiratoy drugs to treat COPD and asthma are on the program, run in conjunction with HealthPrize.
Pharma loses $637 billion annually, with $250 billion in the U.S. alone last year, attributed to patient nonadherence to medications, according to a new study from HealthPrize and Capgemini.
For COPD patients, Starbucks and Amazon rewards are now just a few healthy-behavior clicks away. In a new program from Boehringer Ingelheim, Spiriva Respimat users can earn points they can redeem for prizes.
HealthPrize has talked up gamification as a way to get patients to stick to their meds. Now, the company has new data showing participants in its digital adherence program were more likely to refill their scripts.